Displaying 1 to 20 of 30 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. |
United States | 10 Jun 2011 | Series D |
|
|
|
Applied Genetic Technologies Corp A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. |
United States | N/A |
||
|
|
Arginetix Inc Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. |
United States | 1 Oct 2008 | Seed |
|
|
|
Avidia Inc |
United States | 1 May 2005 | Series B Active |
|
|
|
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | 1 Mar 2008 | Series B Active |
|
|
|
Catabasis Pharmaceuticals Inc |
United States | 1 Apr 2010 | Series A |
|
|
|
Catabasis Pharmaceuticals Inc |
United States | 1 Dec 2011 | Series A |
|
|
|
Cellective Therapeutics Inc |
United States | N/A |
||
|
|
Coferon Inc Develops orally active drugs that act like small drug molecules, can permeate cell membranes, and once inside, can assemble into larger molecules |
United States | 1 Jul 2012 | Series B |
|
|
|
Corridor Pharmaceuticals Inc |
United States | N/A |
||
|
|
Critical Therapeutics Inc Discoverer, developer and commercialize novel therapies. |
United States | N/A |
||
|
|
Elusys Therapeutics Inc Develops antibody-based therapies to treat infectious diseases. |
United States | N/A |
||
|
|
Hydra Biosciences Inc |
United States | N/A |
||
|
|
Inotek Pharmaceuticals Corp Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. |
United States | N/A |
||
|
|
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. |
United States | 31 Dec 2003 | Series C |
|
|
|
LigoCyte Pharmaceuticals Inc |
United States | N/A |
||
|
|
LigoCyte Pharmaceuticals Inc |
United States | N/A |
||
|
|
NeuProtect Pty Ltd |
Australia | N/A |
||
|
|
NKT Therapeutics Inc |
United States | N/A |
||
|
|
Rib-X Pharmaceuticals Inc |
United States | 1 Jan 2009 | N/A |